SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
VPHM - Viropharma Inc
An SI Board Since December 1998
Posts SubjectMarks Bans Symbol
2557 72 0 VPHM
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1532It looks like it was finally introduced to the Senate, just before the adjournmescaram(o)uche-8/9/2003
1531the blueprint for progress..... frist.senate.govscaram(o)uche-8/9/2003
1530Nor can I (GVR) except that if I interpret the table behind this link correctly,tom pope-8/7/2003
1529remember your ML trade? well, watching VPHM, I again got curious about SIZE. Iscaram(o)uche-8/7/2003
1528<i>Meanwhile, the apparent profit generated by Durus from its recent tradiscaram(o)uche-8/5/2003
1527thestreet.com Durus' Esperion Trades Look Well-Timed By Matthew Goldsteinscaram(o)uche-8/5/2003
1526excerpt, Vaxgen release (emphasis mine, no knowledge re. accuracy)...... <i&scaram(o)uche-8/5/2003
1525excerpt from today's (thanks, R!) BioCentury....... Scott Sacane, who managscaram(o)uche-8/4/2003
1524Item 5—Other Events. ViroPharma Incorporated (“ViroPharma”) is filing a set scaram(o)uche-8/1/2003
1523new 8-K FAQ is out. Sorry, can't cut and paste from this source. will get scaram(o)uche-8/1/2003
1522Forget pharma-like margins! Get the dollars flowing through the labs, and let tscaram(o)uche-7/31/2003
1521ndol.org DLC | New Dem Daily | July 24, 2003 Fixing Project Bioshield We have scaram(o)uche-7/31/2003
1520<i>John W. Huggins, Ph.D., chief of Viral Therapeutics at USAMRIID, who pescaram(o)uche-7/31/2003
1519>> but I still haven't a clue as to what drives VPHM's price <&scaram(o)uche-7/30/2003
1518Yes, but I still haven't a clue as to what drives VPHM's price. What drtom pope-7/30/2003
1517<I>Volatility continues to be the watchword for ViroPharma</I> TalkAllan Harris-7/30/2003
1516ViroPharma makes bid for rebound Research finds compound active against smallpoxscaram(o)uche-7/30/2003
1515this post is going to get lost in the mess at yahoo. it's not real-world rescaram(o)uche-7/30/2003
1514>> It's biotech. Get a grip and enjoy. << finance.messages.yahoscaram(o)uche-7/30/2003
1513A bioterror/emerging pathogen business? IMO, VPHM is well-suited to be a leadinscaram(o)uche-7/30/2003
1512Good. I was afraid that you'd be able to parse the release into insignificantom pope-7/30/2003
1511updating the list, now that they've delivered re. item number one....... nescaram(o)uche-7/30/2003
1510Nice way to start the day. <i>EXTON, Pa., July 30, 2003 (PRIMEZONE) -- Vtom pope-7/30/2003
1509short interest down about 200K to 2.9M. Days to cover increases to 10.scaram(o)uche-7/28/2003
1508>>I strongly believe that these guys deserve some low-priced options.<&keokalani'nui-7/24/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News